hemodialysis

Pharmacology
Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy
M. G. Vossen, L. Ehmann, S. Pferschy, A. Maier-Salamon, M. Haidinger, C. Weiser, J. M. Wenisch, K. Saria, C. Kajahn, S. Jilch, R. Lemmerer, M. Bécède, M. Zeitlinger, C. Kloft, W. Jäger, F. Thalhammer
Clinical Therapeutics
Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment
Christopher M. Rubino, Sujata M. Bhavnani, Jeffery S. Loutit, Brooke Lohse, Michael N. Dudley, David C. Griffith
Antiviral Agents
Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects
Matthew P. Kosloski, Weihan Zhao, Thomas C. Marbury, Richard A. Preston, Michael G. Collins, David Pugatch, Federico Mensa, Jens Kort, Wei Liu
Pharmacology
Ethambutol Is Cleared by a Contemporary High-Flux Hemodialyzer, and Drug Monitoring Ensures Safety and Therapeutic Effect
Rusheng Chew, Sarah Jongbloed, Dev Jegatheesan, Helen Healy, Kim Ta, Jacobus Ungerer, Brett McWhinney, Peter Donovan, Marion L. Woods
Pharmacology
Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function
Takayuki Katsube, Toshihiro Wajima, Toru Ishibashi, Juan Camilo Arjona Ferreira, Roger Echols

Main menu